(Page 2 of 2)
the one I put together in July, which included Intellikine ($28.5 million), ParAccel ($22 million), SkinMedica ($9.4 million), Medsphere Systems ($6 million), Afraxis ($3.3 million), and Loop’d Networks ($800,000). The Connect list of top 10 investments shows:
PhotoThera $50.0 million
Ophthonix $25.9 million
Tandem Diabetes Care $13.0 million
Anaphore $13.0 million
aTyr Pharma $10.8 million
Lithera $10.0 million
Aragon Pharmaceuticals $ 8.0 million
Traversa Therapeutics $5.0 million
Nirvanix $5.0 million
MojoPages.com $5.0 million
Some other data points from the Connect report:
—Grants from the National Institutes of Health to researchers in the San Diego region totaled $265.3 million, a 56 percent increase compared to the first quarter. Grants from the National Science Foundation to San Diego recipients rose 14 percent to $56.3 million.
—Patent applications submitted during the second quarter by inventors from the San Diego region increased 15 percent over the first three months, to 1,559. Patents granted by the U.S. Patent and Trademark Office increased by 16 percent to 728. The San Diego area accounted for about 14 percent of the total number of patents filed and granted by inventors throughout California.
—Mergers and acquisitions involving companies in the San Diego area declined during the second quarter, with 24 deals closed compared to 42 deals closed during the first quarter of 2009. Despite that falloff, San Diego companies still accounted for a third of all the M&A deals that closed in Southern California.
The Connect Innovation Report, which is available here, is a joint effort by Connect, the National University System Institute for Policy Research, University of California, San Diego Extension, PricewaterhouseCoopers, Procopio, Cory, Hargreaves & Savitch, and the San Diego Business Journal.